ACHE and early-onset autosomal dominant Alzheimer disease: As such, current symptomatic Alzheimer’s disease treatments, specifically AChE inhibitors donepezil and rivastigmine, act to remediate this cholinergic dysfunction through increasing the level of acetylcholine at the synaptic cleft (Raina et al., 2008).